Press Releases

Centene to Preview Additional Details of Organizational Structure for Combined Company at Investor Day Scheduled for June 14, 2019

Transaction on Track to Close by First Half of 2020

-- 2019 First Quarter Diluted EPS of $1.24; Adjusted Diluted EPS of $1.39 --

Youth contest is part of Centene's national OpiEnd program to raise awareness about opioid misuse and prevention

Partnership to focus on Alzheimer's disease, breast cancer, diabetes, obesity

Transaction Valued at $17.3 Billion Combined Company to Have Approximately 22 Million Members Across All 50 States Increased Scale and Leading Medicare Platform Enhances Growth Transaction Projected to Be Mid-Single Digit Accretive to Adjusted EPS in Year Two Companies to Host Conference Call at 8:00 AM ET

- Live Audio Webcast of Annual Meeting Available - - Reminder: June 14, 2019 Investor Day and 2019 Quarterly Earnings Release Dates in Usual Pattern -

-- 2018 Full Year Diluted EPS of $4.52; Adjusted Diluted EPS of $7.08 --

Joint Venture to Offer Unique Approach to Medicaid Reform in North Carolina

-- CONFIRMS 2018 GUIDANCE --

Plans to release 2019 Financial Guidance after close of market on December 13th

-- 2018 Third Quarter Diluted EPS of $0.09; Adjusted Diluted EPS of $1.79 --

Centene and Ascension to explore acceleration of Medicare Advantage growth by establishing leading Medicare Advantage plan as a preferred model in select markets

-- 2018 Second Quarter Diluted EPS of $1.50; Adjusted Diluted EPS of $1.80 --

Fidelis Care Becomes Centene's Health Plan in New York State

-- 2018 First Quarter Diluted EPS of $1.91; Adjusted Diluted EPS of $2.17 --

-- Live Audio Webcast of Annual Meeting Available --

-- 2017 Full Year Diluted EPS of $4.69; Adjusted Diluted EPS of $5.03 --

--RSVP Requested If Not Already Registered--

-- 2017 Third Quarter Diluted EPS of $1.16; Adjusted Diluted EPS of $1.35 --

Transaction Expected to be Significantly Accretive to Centene's EPS